APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients
Introduction: To better understand the impact of APOL1 risk variants in end-stage renal disease (ESRD) we evaluated associations of APOL1 risk variants with subclinical cardiovascular disease (CVD) and mortality among African Americans initiating hemodialysis and enrolled in the Predictors of Arrhyt...
Main Authors: | Teresa K. Chen, Jessica Fitzpatrick, Cheryl A. Winkler, Elizabeth A. Binns-Roemer, Celia P. Corona-Villalobos, Bernard G. Jaar, Stephen M. Sozio, Rulan S. Parekh, Michelle M. Estrella |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Kidney International Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024920317174 |
Similar Items
-
Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression
by: Ping An, et al.
Published: (2019-01-01) -
APOL1, Sickle Cell Trait, and CKD in the Jackson Heart StudyPlain-Language Summary
by: Bessie A. Young, et al.
Published: (2021-11-01) -
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
by: Gizelle M. McCarthy, et al.
Published: (2021-08-01) -
APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
by: Michael D. Hughson, et al.
Published: (2018-01-01) -
APOL1 Risk Alleles Are Associated With More Severe Arteriosclerosis in Renal Resistance Vessels With Aging and Hypertension
by: Michael D. Hughson, et al.
Published: (2016-05-01)